$RLBD
Real Brands Inc Stock $rlbd

$rlbd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000126493123000015 Filed on April 28, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$20.25K	$2.700K	$11.13K
YoY Change	2575.03%	78.81%	100.59%
Cost Of Revenue	$20.25K	$0.00	$7.507K
YoY Change	13400.0%	-100.0%	-97.14%
Gross Profit	$0.00	$2.700K	$3.626K
YoY Change	-100.0%	-101.41%	-101.41%
Gross Profit Margin	0.0%	100.0%	32.57%
Selling, General & Admin	$155.0K	$109.0K	$795.0K
YoY Change	-29.5%	-59.85%	-61.37%
% of Gross Profit		4038.52%	21924.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.62K	$20.62K	$82.08K
YoY Change	0.0%	-64.84%	-51.01%
% of Gross Profit		763.7%	2263.54%
Operating Expenses	$155.0K	$129.7K	$795.0K
YoY Change	-29.5%	-60.74%	-64.28%
Operating Profit	-$155.0K	-$127.0K	$791.4K
YoY Change	-29.3%	-75.68%	-131.88%
Interest Expense	-$12.81K	-$11.56K	-$32.51K
YoY Change	88.38%	-22.0%	-1.6%
% of Operating Profit			-4.11%
Other Income/Expense, Net			$0.00
YoY Change			-100.0%
Pretax Income	-$188.4K	-$138.5K	-$905.9K
YoY Change	-23.61%	-85.58%	-67.6%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	$188.4K	-$138.5K	$905.9K
YoY Change	-176.39%	-85.58%	-132.4%
Net Earnings / Revenue	930.58%	-5130.37%	8137.47%
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	2.691B shares	2.682B shares	2.681B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.3K	$2.850K	$2.850K
YoY Change	1261.36%	-98.56%	-98.56%
Cash & Equivalents	$122.3K	$2.845K	$2.850K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$0.00	$750.00	$750.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$122.3K	$3.595K	$3.600K
YoY Change	1261.23%	-98.19%	-98.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.116M	$1.158M	$1.158M
YoY Change	-6.88%	-6.62%	-6.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$530.00	$530.00	$530.00
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$1.117M	$1.158M	$1.158M
YoY Change	-6.88%	-6.62%	-6.62%
TOTAL ASSETS
Total Short-Term Assets	$122.3K	$3.595K	$3.600K
Total Long-Term Assets	$1.117M	$1.158M	$1.158M
Total Assets	$1.239M	$1.162M	$1.162M
YoY Change	2.55%	-19.23%	-19.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$504.7K	$2.267K	$98.72K
YoY Change	0.77%	-99.56%	-36.21%
Accrued Expenses	$801.7K	$675.3K	$1.051M
YoY Change	44.08%	67.85%	39.36%
Deferred Revenue
YoY Change
Short-Term Debt	$811.5K	$591.6K	$591.6K
YoY Change	96.2%	73.56%	73.56%
Long-Term Debt Due	$24.65K
YoY Change
Total Short-Term Liabilities	$2.188M	$1.789M	$1.789M
YoY Change	48.77%	37.42%	37.43%
LONG-TERM LIABILITIES
Long-Term Debt	$89.16K	$125.6K	$125.6K
YoY Change	-34.97%	-15.43%	-15.43%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$89.16K	$125.6K	$125.6K
YoY Change	-34.97%	-15.43%	-15.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.188M	$1.789M	$1.789M
Total Long-Term Liabilities	$89.16K	$125.6K	$125.6K
Total Liabilities	$2.277M	$1.915M	$1.915M
YoY Change	41.63%	32.01%	32.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.52M	-$12.57M
YoY Change	10.95%	7.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.038M	-$752.9K	-$752.9K
YoY Change
Total Liabilities & Shareholders Equity	$1.239M	$1.162M	$1.162M
YoY Change	2.55%	-19.23%	-19.23%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$188.4K	-$138.5K	$905.9K
YoY Change	-176.39%	-85.58%	-132.4%
Depreciation, Depletion And Amortization	$20.62K	$20.62K	$82.08K
YoY Change	0.0%	-64.84%	-51.01%
Cash From Operating Activities	-$23.26K	-$234.5K	-$531.5K
YoY Change	-88.04%	-45.31%	-38.6%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$165.0K
YoY Change			-83.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	142.0K	229.1K	$337.1K
YoY Change	-26.14%	415.67%	-65.0%
NET CHANGE
Cash From Operating Activities	-23.26K	-234.5K	-$531.5K
Cash From Investing Activities		0.000	0.000
Cash From Financing Activities	142.0K	229.1K	$337.1K
Net Change In Cash	118.7K	-5.480K	-$194.4K
YoY Change	-5172.65%	-96.36%	283.98%
FREE CASH FLOW
Cash From Operating Activities	-$23.26K	-$234.5K	-$531.5K
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$234.5K	-$531.5K
YoY Change		-64.61%	-25.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001084133
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
CY2022	RLBD	Forgiveness Ppp Loan ForgivenessPppLoan		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
CY2022	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions		usd
CY2021	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss		usd
CY2022	RLBD	Gain On Forgiveness Ppp Loan GainOnForgivenessPppLoan		usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies		usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2021	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties		usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	RLBD	Real Estate And Accumulated Depreciation Life Used For Depreciation RealEstateAndAccumulatedDepreciationLifeUsedForDepreciation	P5Y
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-28027
CY2022	dei	Entity Registrant Name EntityRegistrantName	REAL BRANDS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	40-0014655
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	12 Humbert Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	North Providence
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	RI
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02991
CY2022	dei	City Area Code CityAreaCode	(617)
CY2022	dei	Local Phone Number LocalPhoneNumber	803-0004
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	51122164	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2690640226	shares
CY2022	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2022	dei	Auditor Firm AuditorFirmId	2738
CY2022	dei	Auditor Location AuditorLocation	Houston, TX
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2845	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	197255	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	750	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross		usd
CY2022Q4	us-gaap	Amount Of Impairment To Carrying Amount Of Regulatory Assets AmountOfImpairmentToCarryingAmountOfRegulatoryAssets		usd
CY2021Q4	RLBD	Extended Maturity Date ExtendedMaturityDate	P2Y
CY2018Q4	RLBD	Years Option Exercisable YearsOptionExercisable	P3Y
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	898	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3595	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	198153	usd
CY2022Q4	us-gaap	Deposits Deposits	530	usd
CY2021Q4	us-gaap	Deposits Deposits	530	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1157733	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1239809	usd
CY2022Q4	us-gaap	Assets Assets	1161859	usd
CY2021Q4	us-gaap	Assets Assets	1438492	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	476543	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	513065	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	675349	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	402347	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	75000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	273605	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	133605	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	200000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	200000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	43003	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7250	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	45625	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	45625	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1789125	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1301892	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125629	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	148551	usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	125629	usd
CY2021Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	148551	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1914754	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1450443	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3998000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2690640226	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2690640226	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2677529115	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2677529115	shares
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	2690640	usd
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	2677529	usd
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	6806011	shares
CY2021Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	6806011	shares
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	96403	usd
CY2021Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	96403	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9034617	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8881728	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12574555	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11668611	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-752895	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-11951	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1161859	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1438492	usd
CY2022	us-gaap	Revenues Revenues	11133	usd
CY2021	us-gaap	Revenues Revenues	5546	usd
CY2022	us-gaap	Revenues Revenues	11133	usd
CY2021	us-gaap	Revenues Revenues	5546	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7507	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	262620	usd
CY2022	us-gaap	Gross Profit GrossProfit	3626	usd
CY2021	us-gaap	Gross Profit GrossProfit	-257074	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	252305	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	471494	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	122570	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	194556	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	420112	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	326424	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1065390	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	794987	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2057864	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	791361	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2314938	usd
CY2021	RLBD	Forgiveness Ppp Loan ForgivenessPppLoan	143485	usd
CY2022	us-gaap	Depreciation Depreciation	82076	usd
CY2021	us-gaap	Depreciation Depreciation	167536	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-385989	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37753	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	32507	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	33040	usd
CY2022	us-gaap	Other Income OtherIncome	-114583	usd
CY2021	us-gaap	Other Income OtherIncome	-480833	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-905944	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2795771	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	905944	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2795771	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2680730333	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2624071816	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	695676	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	985001	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1065390	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37753	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2795771	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-11951	usd
CY2022	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	165000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	905944	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-752895	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	905944	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2795771	usd
CY2021	RLBD	Gain On Forgiveness Ppp Loan GainOnForgivenessPppLoan	-143485	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1065390	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37753	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	82076	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	167536	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	148	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-721	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	385989	usd
CY2021	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	230951	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	292233	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	186696	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-531488	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-865664	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	147999	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	75000	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	140000	usd
CY2022	RLBD	Repayment Of Mortgage Payable1 RepaymentOfMortgagePayable1	-22922	usd
CY2021	RLBD	Repayment Of Mortgage Payable1 RepaymentOfMortgagePayable1	-21975	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	20000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	165000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	985001	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	337078	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	963026	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-194410	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-50637	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197255	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	247892	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2845	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197255	usd
CY2022	us-gaap	Interest Paid InterestPaid	7732	usd
CY2021	us-gaap	Interest Paid InterestPaid	8686	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	55753	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	905944	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2795771	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2845	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	197255	usd
CY2021Q4	RLBD	Cash And Cash Equivalents At Carrying Value Increase Decrease CashAndCashEquivalentsAtCarryingValueIncreaseDecrease	194410	usd
CY2022Q4	us-gaap	Capital Capital	1785530	usd
CY2021Q4	us-gaap	Capital Capital	1103739	usd
CY2021Q4	RLBD	Capital Increase Decrease CapitalIncreaseDecrease	681791	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zEBfcLMCiz3f" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of estimates and judgments</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Key areas of estimation include the estimated useful lives of property, plant, equipment and intangibles assets and liabilities, income taxes, and the valuation of stock-based compensation. Due to the uncertainty inherent in such estimates, actual results may differ from the Company’s estimates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"> <b> </b></p>
CY2022Q4	us-gaap	Deposits Deposits	530	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zZupxtocwfZj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Concentrations of Credit Risk</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, from time to time during the years covered by these consolidated financial statements, may have bank balances in excess of its insured limits. Management has deemed this a normal business risk.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2020Q1	RLBD	Shares Issued Of Aquisition Company SharesIssuedOfAquisitionCompany	2000000	shares
CY2020Q1	RLBD	Cash For Building Purchase CashForBuildingPurchase	25000	usd
CY2020Q1	RLBD	Mortgage Assumption MortgageAssumption	189916	usd
CY2020Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	25000	usd
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	475000	usd
CY2021Q4	RLBD	Year Of Depreciation For Improvements YearOfDepreciationForImprovements	P15Y
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29687	usd
CY2021Q4	RLBD	Year Of Depreciation For Improvements YearOfDepreciationForImprovements	P15Y
CY2022	us-gaap	Other Real Estate Non Covered Period Increase Decrease OtherRealEstateNonCoveredPeriodIncreaseDecrease	52388	usd
CY2021Q4	us-gaap	Property Plant And Equipment Salvage Value PropertyPlantAndEquipmentSalvageValue	0	usd
CY2021Q4	us-gaap	Amount Of Impairment To Carrying Amount Of Regulatory Assets AmountOfImpairmentToCarryingAmountOfRegulatoryAssets	385989	usd
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	475000	usd
CY2021Q4	RLBD	Year Of Depreciation Building YearOfDepreciationBuilding	P15Y
CY2022Q4	us-gaap	Option Indexed To Issuers Equity Indexed Shares OptionIndexedToIssuersEquityIndexedShares	154518887	shares
CY2022Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding OwnshareLendingArrangementSharesOutstanding	30192079	shares
CY2021Q4	us-gaap	Option Indexed To Issuers Equity Indexed Shares OptionIndexedToIssuersEquityIndexedShares	154518887	shares
CY2021Q4	us-gaap	Ownshare Lending Arrangement Shares Outstanding OwnshareLendingArrangementSharesOutstanding	28443298	shares
CY2022	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	50
CY2023Q1	us-gaap	Option Indexed To Issuers Equity Indexed Shares OptionIndexedToIssuersEquityIndexedShares	6143628	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	94654420	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0071
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0071
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29687	usd
CY2022Q4	us-gaap	Property Plant And Equipment Salvage Value PropertyPlantAndEquipmentSalvageValue	0	usd
CY2022Q4	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	475000	usd
CY2021Q4	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	475000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	785823	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	785823	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	752553	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1260823	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2013376	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	103089	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387578	usd
CY2021Q4	us-gaap	Amount Of Impairment To Carrying Amount Of Regulatory Assets AmountOfImpairmentToCarryingAmountOfRegulatoryAssets	385989	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1157733	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1239809	usd
CY2015Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	71069.37	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	98720	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	154758	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	371935	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	344410	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3621	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	7330	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2267	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6568	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	476543	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	513065	usd
CY2021Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	7	pure
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	675349	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	45733	usd
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	200000	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	7	pure
CY2022	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	200000	usd
CY2021Q4	RLBD	Percentage Own Converted1 PercentageOwnConverted1	1	pure
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1000000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37753	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	45733	usd
CY2022Q3	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	3111111	shares
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	65000	usd
CY2022Q4	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	10000000	shares
CY2022Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	100000	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2690640226	shares
CY2022Q1	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	1000000	shares
CY2019	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	175000	usd
CY2018Q4	us-gaap	Cash Cash	90000	usd
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	750000	shares
CY2018Q4	RLBD	Common Stock Shares Issued1 CommonStockSharesIssued1	750000	shares
CY2018Q4	RLBD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	150000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.50
CY2018Q4	RLBD	Discount Offering Price DiscountOfferingPrice	25	pure
CY2018Q4	RLBD	Amount Raise AmountRaise	500000	usd
CY2018Q4	RLBD	Additional Cash Payment AdditionalCashPayment	50000	usd
CY2018Q4	RLBD	Timeframe For Payment TimeframeForPayment	30	interger
CY2018Q4	RLBD	Percent Alloted1 PercentAlloted1	0.01	pure
CY2018Q4	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	50000	usd
CY2019Q4	RLBD	Percent Alloted1 PercentAlloted1	0.01	pure
CY2019Q4	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	50000	usd
CY2019Q4	RLBD	Aggregate Amount AggregateAmount	50000	usd
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3500	usd
CY2019Q4	RLBD	Terms Of Contract TermsOfContract	12	interger
CY2019Q4	RLBD	Terms Of Contract TermsOfContract	12	interger
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5482345	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5482345	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5482345	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5482345	usd
CY2022	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Period Increase Decrease ValuationAllowanceForImpairmentOfRecognizedServicingAssetsPeriodIncreaseDecrease	235545	usd
CY2021	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Period Increase Decrease ValuationAllowanceForImpairmentOfRecognizedServicingAssetsPeriodIncreaseDecrease	287504	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5482345	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5246800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5482345	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5246800	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.05	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	21	pure
CY2023Q1	us-gaap	Option Indexed To Issuers Equity Indexed Shares OptionIndexedToIssuersEquityIndexedShares	6143628	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	94654420	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0071
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0071
CY2022	us-gaap	Name Of Prompt Corrective Action Category NameOfPromptCorrectiveActionCategory	On December 21, 2022, the Company received written notice from the OTC Markets Group (“OTC”) notifying the Company that its common shares, $0.001 par value, closed below $0.01 per share for more than 30 consecutive calendar days and no longer meets the Standards for Continued Eligibility for OTCQB as per the OTCQB Standards, Section 2.3(2), which states that the Company must “maintain proprietary priced quotations published by a Market Maker in OTC Link with a minimum closing bid price of $.01 per share on at least one of the prior thirty consecutive calendar days.” As per Section 4.1 of the OTCQB Standards, the Company was granted a cure period of 90 calendar days during which the minimum closing bid price for the Company’s common stock must be $0.01 or greater for ten consecutive trading days in order to continue trading on the OTCQB marketplace.

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001264931-23-000015-index-headers.html	Edgar Link	pending
0001264931-23-000015-index.html	Edgar Link	pending
0001264931-23-000015.txt	Edgar Link	pending
0001264931-23-000015-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
real10k22.htm	Edgar Link	pending
report.css	Edgar Link	pending
rlbd-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rlbd-20221231_def.xml	Edgar Link	unprocessable
rlbd-20221231_cal.xml	Edgar Link	unprocessable
rlbd-20221231_lab.xml	Edgar Link	unprocessable
rlbd-20221231_pre.xml	Edgar Link	unprocessable
real10k22_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RLBD
Real Brands Inc Stock $rlbd

2023 Q2 Form 10-K Financial Statement

#000126493123000015 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RLBD Real Brands Inc Stock $rlbd

2023 Q2 Form 10-K Financial Statement

#000126493123000015 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RLBD
Real Brands Inc Stock $rlbd